Point72 Asia (Singapore) Pte. Ltd. Seres Therapeutics, Inc. Transaction History

Point72 Asia (Singapore) Pte. Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.48 $57,863 - $122,339	-82,662 Reduced 64.76%	44,972 $42.5 Million
Q2 2024 Aug 14, 2024	BUY	$0.56 - $1.19 $71,475 - $151,884	127,634 New	127,634 $92.4 Million
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $2,656 - $6,140	2,856 New	2,856 $4 Million

39.5M

103K

53K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $906M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.